PREFUL MRI Reveals Distinct Lung Phenotype in Children With Long COVID
By Elana Gotkine HealthDay Reporter
THURSDAY, Feb. 27, 2025 -- Free-breathing phase-resolved functional lung (PREFUL) magnetic resonance imaging (MRI)-derived parameters can identify a distinct lung phenotype in children and adolescents with post-COVID-19 condition (PCC), according to a study published online Feb. 25 in Radiology.
Gesa H. Pöhler, M.D., from Hannover Medical School in Germany, and colleagues conducted a single-center, prospective, cross-sectional study between April 2022 and April 2023 involving children and adolescents aged 17 years and younger with PCC and matched healthy participants to detect lung changes using PREFUL MRI.
The analysis included 54 participants: 27 with PCC and 27 matched controls; 21 had cardiopulmonary symptoms. The researchers found that participants with PCC had lower regional ventilation and quantified perfusion. Compared with matched control participants, participants with PCC and cardiopulmonary symptoms had lower flow-volume loop correlation metrics and higher ventilation defect and perfusion defect percentage. Greater lung perfusion correlated with increased chronic fatigue severity and higher ventilation-perfusion mismatch correlated with increased heart rate in participants with PCC.
"Phase-resolved functional lung MRI reveals a distinct perfusion phenotype in children and adolescents with PCC, correlating with heart rate and chronic fatigue severity," the authors write. "These findings enhance our understanding of PCC pathophysiologic structure and establish a foundation for future research."
Several authors disclosed ties to the pharmaceutical and medical technology industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted February 2025
Further Support and Information on COVID-19
Read this next
Larazotide May Speed Recovery in Children With Multisystem Inflammatory Syndrome
WEDNESDAY, Aug. 6, 2025 -- Treatment of multisystem inflammatory syndrome in children (MISC), a postacute sequela of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)...
COVID-19 mRNA Vaccine Targeting Omicron JN.1 Lineage Safe
WEDNESDAY, Aug. 6, 2025 -- Vaccination with the updated COVID-19 mRNA vaccine containing the severe acute respiratory syndrome coronavirus-2 Omicron JN.1 lineage was not...
Prevalence of Disorders of Gut-Brain Interaction Increased After Pandemic
TUESDAY, Aug. 5, 2025 -- The prevalence of disorders of the gut-brain interaction (DGBI) increased from before to after the COVID-19 pandemic, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.